343 related articles for article (PubMed ID: 19642967)
1. In silico drug discovery approaches on grid computing infrastructures.
Wolf A; Shahid M; Kasam V; Ziegler W; Hofmann-Apitius M
Curr Clin Pharmacol; 2010 Feb; 5(1):37-46. PubMed ID: 19642967
[TBL] [Abstract][Full Text] [Related]
2. WISDOM-II: screening against multiple targets implicated in malaria using computational grid infrastructures.
Kasam V; Salzemann J; Botha M; Dacosta A; Degliesposti G; Isea R; Kim D; Maass A; Kenyon C; Rastelli G; Hofmann-Apitius M; Breton V
Malar J; 2009 May; 8():88. PubMed ID: 19409081
[TBL] [Abstract][Full Text] [Related]
3. Design of a grid service-based platform for in silico protein-ligand screenings.
Levesque MJ; Ichikawa K; Date S; Haga JH
Comput Methods Programs Biomed; 2009 Jan; 93(1):73-82. PubMed ID: 18771812
[TBL] [Abstract][Full Text] [Related]
4. Hydra: a self regenerating high performance computing grid for drug discovery.
Bullard D; Gobbi A; Lardy MA; Perkins C; Little Z
J Chem Inf Model; 2008 Apr; 48(4):811-6. PubMed ID: 18338845
[TBL] [Abstract][Full Text] [Related]
5. Advances in distributed computing with modern drug discovery.
Banegas-Luna AJ; Imbernón B; Llanes Castro A; Pérez-Garrido A; Cerón-Carrasco JP; Gesing S; Merelli I; D'Agostino D; Pérez-Sánchez H
Expert Opin Drug Discov; 2019 Jan; 14(1):9-22. PubMed ID: 30484337
[TBL] [Abstract][Full Text] [Related]
6. Combining label-free cell phenotypic profiling with computational approaches for novel drug discovery.
Fang Y
Expert Opin Drug Discov; 2015 Apr; 10(4):331-43. PubMed ID: 25727255
[TBL] [Abstract][Full Text] [Related]
7. Free resources to assist structure-based virtual ligand screening experiments.
Villoutreix BO; Renault N; Lagorce D; Sperandio O; Montes M; Miteva MA
Curr Protein Pept Sci; 2007 Aug; 8(4):381-411. PubMed ID: 17696871
[TBL] [Abstract][Full Text] [Related]
8. Toward fully automated high performance computing drug discovery: a massively parallel virtual screening pipeline for docking and molecular mechanics/generalized Born surface area rescoring to improve enrichment.
Zhang X; Wong SE; Lightstone FC
J Chem Inf Model; 2014 Jan; 54(1):324-37. PubMed ID: 24358939
[TBL] [Abstract][Full Text] [Related]
9. Role of computer-aided drug design in modern drug discovery.
Macalino SJ; Gosu V; Hong S; Choi S
Arch Pharm Res; 2015 Sep; 38(9):1686-701. PubMed ID: 26208641
[TBL] [Abstract][Full Text] [Related]
10. Grid heterogeneity in in-silico experiments: an exploration of drug screening using DOCK on cloud environments.
Yim WW; Chien S; Kusumoto Y; Date S; Haga J
Stud Health Technol Inform; 2010; 159():181-90. PubMed ID: 20543437
[TBL] [Abstract][Full Text] [Related]
11. How to Prepare a Compound Collection Prior to Virtual Screening.
Bologa CG; Ursu O; Oprea TI
Methods Mol Biol; 2019; 1939():119-138. PubMed ID: 30848459
[TBL] [Abstract][Full Text] [Related]
12. Quantum mechanics implementation in drug-design workflows: does it really help?
Arodola OA; Soliman ME
Drug Des Devel Ther; 2017; 11():2551-2564. PubMed ID: 28919707
[TBL] [Abstract][Full Text] [Related]
13. Computer-aided drug discovery research at a global contract research organization.
Kitchen DB
J Comput Aided Mol Des; 2017 Mar; 31(3):309-318. PubMed ID: 27804014
[TBL] [Abstract][Full Text] [Related]
14. 1001 Ways to run AutoDock Vina for virtual screening.
Jaghoori MM; Bleijlevens B; Olabarriaga SD
J Comput Aided Mol Des; 2016 Mar; 30(3):237-49. PubMed ID: 26897747
[TBL] [Abstract][Full Text] [Related]
15. ProSelection: A Novel Algorithm to Select Proper Protein Structure Subsets for in Silico Target Identification and Drug Discovery Research.
Wang N; Wang L; Xie XQ
J Chem Inf Model; 2017 Nov; 57(11):2686-2698. PubMed ID: 29016123
[TBL] [Abstract][Full Text] [Related]
16. Design of new plasmepsin inhibitors: a virtual high throughput screening approach on the EGEE grid.
Kasam V; Zimmermann M; Maass A; Schwichtenberg H; Wolf A; Jacq N; Breton V; Hofmann-Apitius M
J Chem Inf Model; 2007; 47(5):1818-28. PubMed ID: 17727268
[TBL] [Abstract][Full Text] [Related]
17. Combating Diseases with Computational Strategies Used for Drug Design and Discovery.
Makhouri FR; Ghasemi JB
Curr Top Med Chem; 2018; 18(32):2743-2773. PubMed ID: 30663568
[TBL] [Abstract][Full Text] [Related]
18. Virtual Screening Techniques and Current Computational Infrastructures.
Haga JH; Ichikawa K; Date S
Curr Pharm Des; 2016; 22(23):3576-84. PubMed ID: 27075580
[TBL] [Abstract][Full Text] [Related]
19. Computational chemistry at Janssen.
van Vlijmen H; Desjarlais RL; Mirzadegan T
J Comput Aided Mol Des; 2017 Mar; 31(3):267-273. PubMed ID: 27995515
[TBL] [Abstract][Full Text] [Related]
20. In-silico approaches to multi-target drug discovery : computer aided multi-target drug design, multi-target virtual screening.
Ma XH; Shi Z; Tan C; Jiang Y; Go ML; Low BC; Chen YZ
Pharm Res; 2010 May; 27(5):739-49. PubMed ID: 20221898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
